Power injection valve

Information

  • Patent Grant
  • 8523821
  • Patent Number
    8,523,821
  • Date Filed
    Wednesday, November 23, 2011
    13 years ago
  • Date Issued
    Tuesday, September 3, 2013
    12 years ago
Abstract
A device for transferring fluids between an internal structure in a living body and an exterior thereof comprises a housing including a pressure activated lumen extending to a distal end opening to a power injection lumen that extends to a distal port configured for connection to a fluid conduit extending to a target structure within the body and a pressure activated valve extending across the pressure activated lumen and controlling fluid flow therethrough, in combination with a proximal port coupled to the housing for movement between a first position in which a proximal end of the power injection lumen opens to the proximal port and a second position in which a proximal end of the pressure activated lumen opens to the proximal port.
Description
BACKGROUND

Procedures requiring the use of peripherally inserted central catheters (“PICC”) often employ pressure activated valves to seal these catheters when not in use. Such pressure activated valves are designed to remain closed during normal pressure fluctuations between uses to prevent leakage and backflow which may lead to occlusions and/or infections. However, these valves have often been unsuitable for the injection of fluids at high pressures or volumes.


SUMMARY OF THE INVENTION

The present invention is directed to a device for transferring fluids between an internal structure in a living body and an exterior thereof, comprises a housing including a pressure activated lumen extending to a distal end opening to a power injection lumen that extends to a distal port configured for connection to a fluid conduit extending to a target structure within the body and a pressure activated valve extending across the pressure activated lumen and controlling fluid flow therethrough, the pressure activated valve opening to permit fluid flow therethrough into the power injection lumen when a fluid pressure differential thereacross is at least a first predetermined threshold level and remaining sealed when the fluid pressure differential thereacross is less than the first threshold level in combination with a proximal port coupled to the housing for movement between a first position in which a proximal end of the power injection lumen opens to the proximal port and a second position in which a proximal end of the pressure activated lumen opens to the proximal port.


The present invention is further directed to a method for transferring fluids between a target internal structure of a living body and an exterior of the body, the method comprising connecting to a proximal end of a fluid conduit extending into the body to the target structure a distal port of a housing opening to a power injection lumen thereof, the housing including a pressure activated lumen extending to a distal end opening to the power injection lumen with a pressure activated valve opening to permit fluid flow therethrough into the power injection lumen when a fluid pressure differential thereacross is at least a first predetermined threshold level and remaining sealed when the fluid pressure differential thereacross is less than the first threshold level and moving a proximal port of the housing to a first position in which the proximal port is fluidly coupled to the power injection lumen in combination with supplying a first fluid to the proximal port at a power injection pressure greater than the first threshold level, moving the proximal port of the housing to a first position in which the proximal port is fluidly coupled to the pressure activated lumen and supplying a second fluid to the proximal port at a pressure greater than the first threshold level and less than the power injection pressure.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawing illustrates the design of the present invention wherein:



FIG. 1 shows a first view of an apparatus according to a first embodiment of the present invention;



FIG. 2 shows an exploded view of the device of FIG. 1;



FIG. 3 shows an internal view of the device of FIG. 1;



FIG. 4 shows a side view of the device of FIG. 1;



FIG. 5 shows a bottom view of the device of FIG. 1;



FIG. 6 shows a top view of the device of FIG. 1;



FIG. 7 shows a perspective view of the device of FIG. 1 in a position permitting flow through a pressure activated valve; and



FIG. 8 shows a perspective view of the device of FIG. 1 in a normal flow position.





DETAILED DESCRIPTION

The present invention, which may be further understood with reference to the following description and the appended drawings, relates to a system and method for high pressure and high volume injection without damaging a pressure activated valve. In particular, the present invention relates to the selective engagement for high pressure and high volume injection of separate lumens within a device employed in conjunction with a catheter (e.g., a PICC catheter) with at least one of the lumens employing a pressure activated valve.


Presently available pressure activated valves are generally unable to sustain the high pressures and flow rates associated with power injection (e.g., of contrast media). An exemplary embodiment of the present invention seeks to alleviate this problem by incorporating with a pressure activated valve a bypass feature allowing power injection without damaging the pressure activated valve.


As shown in FIGS. 1-8, a port 100 according to a first embodiment of the invention includes two passages which may be selectively engaged to select either power injection or standard infusion/withdrawal of fluids. The port 100 comprises a base 110 and a cover 120 joined together, for example, via any known means such as bonding, welding, friction fit, etc. Protruding distally from the port 100 is an elongated tubular body 105 with a lumen 115 extending therethrough and into the base 110, as will be described in greater detail below. It is noted that the term proximal as referred to herein refers to a direction approaching a user or point of user access to the device while distal refers to a direction toward an interior of the body of the patient.


The tubular body 105 is provided with a barbed fitting comprising a series of ridged portions 106 designed to frictionally engage a catheter disposed thereover. Specifically, the ridged portions 106 are formed with a diameter sized to frictionally engage inner walls of a catheter, thereby firmly securing the catheter to the port 100. Accordingly, to mate to the port 100, a catheter is guided over the tubular body 105 to a proximal-most position and frictionally retained thereon. In an alternate embodiment, the tubular body 105 may be insert molded on the catheter, as those skilled in the art will understand.


As shown in the exploded view of FIG. 2, a silicone disk 130 is provided in the port 100, in engagement with a correspondingly sized recess 131 in the base 110 which opens to the lumen 115. The silicone disk 130 effectively regulates the pressure and flow of fluids passing therethrough the port 100. As would be understood by those skilled in the art, the disk 130 may be formed in any desired configuration to obtain desired flow configurations. For example, the disk 130 and a slot or slots therethrough may be formed as shown for any of slitted membranes disclosed in U.S. patent application Ser. No. 10/768,571 entitled “Pressure Activated Safety Valve With Anti-Adherent Coating” filed on Jan. 29, 2004 to Weaver, et al. (the '571 app.); U.S. application Ser. No. 10/768,565 entitled “Pressure Activated Safety Valve With High Flow Slit” filed on even day herewith naming Karla Weaver and Paul DiCarlo as inventors, and U.S. application Ser. No. 10/768,629 entitled “Stacked Membrane For Pressure Actuated Valve” filed on even day herewith naming Karla Weaver and Paul DiCarlo as inventors, and U.S. application Ser. No. 10/768,855 entitled “Pressure Actuated Safety Valve With Spiral Flow Membrane” filed on even day herewith naming Paul DiCarlo and Karla Weaver as inventors, and U.S. application Ser. No. 10/768,479 entitled “Dual Well Port Device” filed on even day herewith naming Katie Daly, Kristian DiMatteo and Eric Houde as inventors. The entire disclosures of each of these applications are hereby incorporated by reference in this application. The silicone disk 130 is held in place over the recess 131 via a disk retainer 135 which engages a periphery thereof. When the cover 120 is mounted to the base 110, a portion of the cover 120 engages the disk retainer 135 applying pressure against the disk 130 to hold the disk 130 against a periphery of the recess 131 and prevent the silicone disk 130 from being moved therefrom.


A rotating luer 150 engages a proximal end of the base 110 at a proximal end of the port 100, as further shown in FIG. 3. The rotating luer 150 includes a lumen 155 extending therethrough from a proximal end 151 to a distal end 152 and at least two tabs 160 extending therefrom about a circumference of an end plate 158 of the luer 150 which preferably forms a substantially continuous surface with the portion of the port 100 (i.e., proximal ends of the base 110 and the cover 120 regardless of a rotational orientation of the luer 150. The tabs 160 indicate an alignment of the lumen 155 in relation to the two lumens 115 and 125 of the port 100, as will be described in greater detail below. The luer 150 also includes a disk-shaped mating projection 156 which is received within a correspondingly shaped and sized slot 154 to rotatably secure the luer 150 to the base 110.


Two O-rings 140 are provided between the rotating luer 150 and the upper and lower body portions 120, 110 to provide a fluid seal therebetween. However, those skilled in the art will understand that any number of O-rings may be provided in the device and these O-rings may vary in thickness and size to obtain the desired seal. The O-rings may exhibit elastomeric properties and may, in an exemplary embodiment, be received in recesses formed on a proximal faces of the base 110 and the cover 120 around proximal openings to the lumens 115, 125, respectively.


As shown in FIG. 3, when in a pressure activated position, the lumen 155 of the luer 150 is aligned with the lumen 125 of the cover 120 which opens to the disk 130. As would be understood by those skilled in the art, when a pressure differential between the lumen 125 and the lumen 115 exceeds a predetermined threshold, edges of the slit(s) in the disk 130 are moved apart from one another and fluid will flow through the disk 130 into the lumen 115 to a catheter attached thereto. When the pressure differential remains below the predetermined threshold, the disk 130 remains sealed preventing fluid flow from the lumen 115 to the lumen 125.


In order to configure the port 100 in the pressure activated position as also shown in FIGS. 6 and 7, a user of the port 100 rotates the luer 150 until the tabs 160 are aligned with corresponding projections (e.g., projections 161) on the port distal body of the port 100 (i.e., the base 110 and/or the cover 120) to an indicated pressure activated position. Specifically, the proximal portion of the port 100 may be labeled to indicate the locations of the lumens 115 and 125, as shown in FIGS. 5 and 6. A physician may then rotate the proximal portion of the port 100 to align the tabs 160 with the projections 161. Rotating the proximal portion of the port 100 in either a clockwise or counter-clockwise direction until the lumen 155 aligns with the desired lumen of the port 100 engages the desired one of the lumens 125 and 115. It is further noted that, when the tabs 160 are not aligned with the projections 161, the port 100 is in an off position with both of the lumens 115 and 125 sealed to prevent the flow of fluid into or out of the proximal portion of the device.


Once the pressure activated valve has been selected, the flow of fluid through the port 100 is guided through the pressure activated valve, as detailed above, with fluid entering the port 100 through an externally attached fluid source via an attachment means shown at the proximal end 151 of the rotating luer 150. The fluid flows through the lumen 155 and into the lumen 125 and, when the pressure differential exceeds the predetermined threshold level, past the silicone disk 130 into the lumen 115 via the recess 131. The fluid is passes through the lumen 115 toward the elongated tubular body 105 as flow toward the proximal end of the lumen 115 is prevented by the fluid-tight seal formed by the distal face of the rotating luer 150 which covers the proximal opening to the lumen 115 when the pressure activated valve has been selected. The fluid flows out of the distal opening of the elongated tubular body 105 to a targeted site in the body via a catheter or other device attached to the tubular body portion 105 as would be understood by those skilled in the art.


Alternatively, if the “<5 mL/s” marker is selected, as shown in FIGS. 5 and 8, the lumen 155 is connected directly to the lumen 115 located inside the base 110 of the port 100. An external high pressure or high volume fluid source may then be attached to a proximal end of the port 100 so that high pressure and/or high volume fluid (e.g., at flow rates and pressures suitable for the power injection of contrast media) supplied to the port 100 passes directly through the lumen 115 to the distal opening in the body 105 and into the catheter without passing through the disk 130. It is further noted that the diameter of the lumen 155 may be substantially similar to the diameter of the lumen 115 to allow for an undeterred flow of fluid therethrough.


The present invention has been described with respect to particular designs and embodiments. However, those skilled in the art will understand that the described exemplary embodiments of the present invention may be altered without departing from the spirit or scope of the invention. For example, the port 100 may be altered in geometry, with the diameters of the either of the lumens 115, 125 and 155 increased or decreased to accommodate the requirements of a patient or procedure for which they are intended. Furthermore, a design may be incorporated with each of the lumens 115 and 125 identified by a different color or pattern of colors, eliminating the need for written markings on the outer body of the port 100.


It is to be understood that these embodiments have been described in an exemplary manner and are not intended to limit the scope of the invention which is intended to cover all modifications and variations of this invention that come within the scope of the appended claims and their equivalents. The specifications are, therefore, to be regarded in an illustrative rather than a restrictive sense.

Claims
  • 1. A valve assembly for a catheter, comprising: a housing defining first and second lumens therethrough;a pressure activated valve disposed between the first and second lumens, the valve adapted to permit fluid to flow from the first lumen to the second lumen when acted upon by a fluid pressure in excess of a predetermined threshold;an outlet fluidly coupled to the second lumen; andan inlet moveable between a first position and a second position, wherein the inlet engages the first lumen when it is in the first position, and the inlet engages the second lumen when it is in the second position.
  • 2. The valve assembly of claim 1, wherein the pressure activated valve prevents fluid flow from the second lumen to the first lumen.
  • 3. The valve assembly of claim 1, wherein the inlet rotates between the first and second positions.
  • 4. The valve assembly of claim 1, wherein the inlet includes a first alignment feature, the housing includes a second alignment feature, and each of said first and second alignment features align when the inlet is placed in at least one of the first and second positions.
  • 5. The valve assembly of claim 4, wherein said first and second alignment features visibly align when the inlet is placed into at least one of the first and second positions.
  • 6. The valve assembly of claim 1, wherein the inlet includes first and second tabs, the first tab positioned to contact a portion of the housing when the inlet is in the first position, the second tab positioned to contact a portion of the housing when the inlet is in the second position.
  • 7. The valve assembly of claim 1, further comprising first and second sealing O-rings disposed at first and second fluid junctions between the moveable inlet and the first and second lumens, respectively.
  • 8. The valve assembly of claim 1, wherein the first lumen includes a surface acutely angled relative to the pressure-activated valve.
  • 9. A system for power injection of fluids into a patient, comprising: a catheter having a distal end insertable into a patient, a proximal hub opposite the distal end, and defining a first lumen therethrough; anda valve assembly, comprising: a housing defining second and third lumens therethrough;a pressure activated valve disposed between the second and third lumens, the valve adapted to permit fluid to flow from the second lumen to the third lumen when acted upon by a fluid pressure in excess of a predetermined threshold;an outlet fluidly coupling the second lumen to the third lumen; andan inlet moveable between a first position and a second position, wherein the inlet engages the second lumen when it is in the first position, and the inlet engages the third lumen when it is in the second position.
  • 10. The system of claim 9, wherein the pressure activated valve prevents fluid flow from the third lumen to the second lumen.
  • 11. The system of claim 9, wherein the inlet rotates between the first and second positions.
  • 12. The system of claim 9, wherein the inlet includes a first alignment feature, the housing includes a second alignment feature, and each of said first and second alignment features align when the inlet is placed in at least one of the first and second positions.
  • 13. The system of claim 12, wherein said first and second alignment features visibly align when the inlet is placed into at least one of the first and second positions.
  • 14. The system of claim 9, wherein the inlet includes first and second tabs, the first tab positioned to contact a portion of the housing when the inlet is in the first position, the second tab positioned to contact a portion of the housing when the inlet is in the second position.
  • 15. The system of claim 9, further comprising first and second sealing O-rings disposed at first and second fluid junctions between the moveable inlet and the second and third lumens, respectively.
  • 16. A system for power injection of fluids into a patient, comprising: a catheter having a distal end insertable into a patient, a proximal hub opposite the distal end, and defining a first lumen therethrough; anda valve assembly, comprising: a housing defining second and third lumens therethrough, the housing including, at one end, a wall having a circular aperture therethrough and, at an opposite end, an outlet fluidly connected to said catheter and said third lumen;a pressure activated valve disposed between the second and third lumens, the valve adapted to permit fluid to flow from the second lumen to the third lumen when acted upon by a fluid pressure in excess of a predetermined threshold; anda rotating luer assembly moveable between first and second positions, the luer assembly comprising a rotating luer tip moveable between first and second positions, wherein the luer, when in the first position, is fluidly connected to the second lumen and, when in the second position, is fluidly connected to the third lumen,wherein the rotating luer is disposed within the circular aperture of the housing.
  • 17. The system of claim 16, wherein the pressure activated valve prevents fluid flow from the third lumen to the second lumen.
  • 18. The system of claim 16, wherein the rotating luer includes a first alignment feature, the housing includes a second alignment feature, and each of said first and second alignment features align when the rotating luer is placed in at least one of the first and second positions.
  • 19. The system of claim 18, wherein said first and second alignment features visibly align when the inlet is placed into at least one of the first and second positions.
  • 20. The system of claim 16, wherein said rotating luer includes first and second tabs, the first tab positioned to contact a portion of the housing when the luer is in the first position, the second tab positioned to contact a portion of the housing when the luer is in the second position.
  • 21. The system of claim 16, further comprising first and second sealing O-rings disposed at first and second fluid junctions between the rotating luer and the second and third lumens, respectively.
CROSS-REFERENCE TO PRIOR APPLICATIONS

This application is a continuation of, and claims priority to, U.S. application Ser. No. 12/362,004, filed on Jan. 29, 2009 now U.S. Pat. No. 8,083,721.

US Referenced Citations (166)
Number Name Date Kind
2446571 Browne Mar 1944 A
2720881 Weaver et al. Oct 1955 A
2755060 Twyman Jul 1956 A
3113586 Edmark, Jr. Dec 1963 A
3159175 MacMillan Dec 1964 A
3159176 Russell et al. Dec 1964 A
3477438 Allen et al. Nov 1969 A
3514438 Nelsen et al. May 1970 A
3525357 Koreski Aug 1970 A
3621557 Cushman et al. Nov 1971 A
3669323 Harker et al. Jun 1972 A
3673612 Merrill et al. Jul 1972 A
3674183 Venable et al. Jul 1972 A
3710942 Rosenberg Jan 1973 A
3788327 Donowitz et al. Jan 1974 A
3811466 Ohringer May 1974 A
3941149 Mittleman Mar 1976 A
3955594 Snow May 1976 A
4072146 Howes Feb 1978 A
4142525 Binard et al. Mar 1979 A
4143853 Abramson Mar 1979 A
4244379 Smith Jan 1981 A
4387879 Tauschinski Jun 1983 A
4405316 Mittleman Sep 1983 A
4434810 Atkinson Mar 1984 A
4447237 Frisch et al. May 1984 A
4468224 Enzmann et al. Aug 1984 A
4502502 Krug Mar 1985 A
4524805 Hoffman Jun 1985 A
4543087 Sommercorn et al. Sep 1985 A
4552553 Schulte et al. Nov 1985 A
4610665 Matsumoto et al. Sep 1986 A
4616768 Flier Oct 1986 A
4646945 Steiner et al. Mar 1987 A
4673393 Suzuki et al. Jun 1987 A
4681572 Tokarz et al. Jul 1987 A
4692146 Hilger Sep 1987 A
4722725 Sawyer et al. Feb 1988 A
4790832 Lopez Dec 1988 A
4798594 Hillstead Jan 1989 A
4801297 Mueller Jan 1989 A
4908028 Colon et al. Mar 1990 A
4944726 Hilal et al. Jul 1990 A
4946448 Richmond Aug 1990 A
4960412 Fink Oct 1990 A
5000745 Guest et al. Mar 1991 A
5009391 Steigerwald Apr 1991 A
5030210 Alchas et al. Jul 1991 A
5084015 Moriuchi Jan 1992 A
5098405 Peterson et al. Mar 1992 A
5125893 Dryden Jun 1992 A
5147332 Moorehead Sep 1992 A
5149327 Oshiyama Sep 1992 A
5167638 Felix et al. Dec 1992 A
5169393 Moorehead et al. Dec 1992 A
5176652 Littrell Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5201722 Moorehead et al. Apr 1993 A
5205834 Moorehead et al. Apr 1993 A
5249598 Schmidt Oct 1993 A
5253765 Moorehead et al. Oct 1993 A
5324274 Martin Jun 1994 A
5330424 Palmer et al. Jul 1994 A
5336203 Goldhardt et al. Aug 1994 A
5360407 Leonard et al. Nov 1994 A
5370624 Edwards et al. Dec 1994 A
5396925 Poli et al. Mar 1995 A
5399168 Wadsworth et al. Mar 1995 A
5401255 Sutherland et al. Mar 1995 A
D357735 McPhee Apr 1995 S
5405340 Fageol et al. Apr 1995 A
5411491 Goldhardt et al. May 1995 A
5453097 Paradis Sep 1995 A
5454784 Atkinson et al. Oct 1995 A
5469805 Gibbs et al. Nov 1995 A
5470305 Arnett et al. Nov 1995 A
5484420 Russo Jan 1996 A
5542923 Ensminger et al. Aug 1996 A
5545150 Danks et al. Aug 1996 A
5554136 Luther Sep 1996 A
5562618 Cai et al. Oct 1996 A
5571093 Cruz et al. Nov 1996 A
5575769 Vaillancourt et al. Nov 1996 A
5624395 Mikhail et al. Apr 1997 A
5637099 Durdin et al. Jun 1997 A
5667500 Palmer et al. Sep 1997 A
5707357 Mikhail et al. Jan 1998 A
5743873 Cai et al. Apr 1998 A
5743884 Hasson et al. Apr 1998 A
5743894 Swisher Apr 1998 A
5752938 Flatland et al. May 1998 A
5803078 Brauner Sep 1998 A
5807349 Person et al. Sep 1998 A
5810789 Powers et al. Sep 1998 A
5843044 Moorehead Dec 1998 A
5853397 Shemesh et al. Dec 1998 A
5865308 Qin et al. Feb 1999 A
5944698 Fischer et al. Aug 1999 A
5984902 Moorehead Nov 1999 A
5989233 Yoon Nov 1999 A
6033393 Balbierz et al. Mar 2000 A
6045734 Luther et al. Apr 2000 A
6050934 Mikhail et al. Apr 2000 A
6056717 Finch et al. May 2000 A
6062244 Arkans May 2000 A
6092551 Bennett Jul 2000 A
6120483 Davey et al. Sep 2000 A
6152129 Berthon-Jones Nov 2000 A
6210366 Sanfilippo Apr 2001 B1
6227200 Crump et al. May 2001 B1
6270489 Wise et al. Aug 2001 B1
6306124 Jones et al. Oct 2001 B1
6364861 Feith et al. Apr 2002 B1
6364867 Wise et al. Apr 2002 B2
6375637 Campbell et al. Apr 2002 B1
6436077 Davey et al. Aug 2002 B1
6442415 Bis et al. Aug 2002 B1
6446671 Armenia et al. Sep 2002 B2
6508791 Guerrero Jan 2003 B1
6551270 Bimbo et al. Apr 2003 B1
6610031 Chin Aug 2003 B1
6726063 Stull et al. Apr 2004 B2
6786884 DeCant et al. Sep 2004 B1
6874999 Dai et al. Apr 2005 B2
6953450 Baldwin et al. Oct 2005 B2
6994314 Garnier et al. Feb 2006 B2
7081106 Guo et al. Jul 2006 B1
7252652 Moorehead et al. Aug 2007 B2
7291133 Kindler et al. Nov 2007 B1
7316655 Garibotto et al. Jan 2008 B2
7435236 Weaver et al. Oct 2008 B2
7601141 Dikeman et al. Oct 2009 B2
7637893 Christensen et al. Dec 2009 B2
7758541 Wallace et al. Jul 2010 B2
20010023333 Wisse et al. Sep 2001 A1
20010037079 Burbank et al. Nov 2001 A1
20020010425 Guo et al. Jan 2002 A1
20020016584 Wise et al. Feb 2002 A1
20020121530 Socier Sep 2002 A1
20020165492 Davey et al. Nov 2002 A1
20020193752 Lynn Dec 2002 A1
20030122095 Wilson et al. Jul 2003 A1
20040034324 Seese et al. Feb 2004 A1
20040064128 Raijman et al. Apr 2004 A1
20040102738 Dikeman May 2004 A1
20040108479 Garnier et al. Jun 2004 A1
20040186444 Daly et al. Sep 2004 A1
20040193119 Canaud et al. Sep 2004 A1
20040210194 Bonnette et al. Oct 2004 A1
20040267185 Weaver et al. Dec 2004 A1
20050010176 Dikeman et al. Jan 2005 A1
20050027261 Weaver et al. Feb 2005 A1
20050043703 Nordgren Feb 2005 A1
20050049555 Moorehead et al. Mar 2005 A1
20050149116 Edwards et al. Jul 2005 A1
20050171490 Weaver et al. Aug 2005 A1
20050171510 DiCarlo et al. Aug 2005 A1
20050283122 Nordgren Dec 2005 A1
20060129092 Hanlon et al. Jun 2006 A1
20060135949 Rome et al. Jun 2006 A1
20060149211 Simpson et al. Jul 2006 A1
20070161940 Blanchard et al. Jul 2007 A1
20070161970 Spohn et al. Jul 2007 A1
20070276313 Moorehead et al. Nov 2007 A1
20080108956 Lynn et al. May 2008 A1
20090292252 Lareau et al. Nov 2009 A1
Foreign Referenced Citations (30)
Number Date Country
20208420 Oct 2002 DE
0128625 Dec 1984 EP
0337617 Oct 1989 EP
0864336 Sep 1998 EP
0930082 Jul 1999 EP
1016431 Jul 2000 EP
2508008 Dec 1982 FR
2718969 Oct 1995 FR
966137 Aug 1964 GB
2102398 Feb 1983 GB
59133877 Aug 1984 JP
63255057 Oct 1988 JP
9038197 Feb 1997 JP
WO-8902764 Apr 1989 WO
WO-9112838 Sep 1991 WO
WO-9206732 Apr 1992 WO
WO-9516480 Jun 1995 WO
WO-96017190 Jun 1996 WO
WO-96023158 Aug 1996 WO
WO-96041649 Dec 1996 WO
WO-97023255 Jul 1997 WO
WO-97026931 Jul 1997 WO
WO-9822178 May 1998 WO
WO-9942166 Aug 1999 WO
WO-0006230 Feb 2000 WO
WO-0044419 Aug 2000 WO
WO-0174434 Oct 2001 WO
WO-03084832 Oct 2003 WO
WO-2005023355 Mar 2005 WO
WO-2008089985 Jul 2008 WO
Non-Patent Literature Citations (14)
Entry
Asch, “Venous access: options, approaches and issues,” Can Assoc. Radiol J., vol. 52, No. 3 pp. 153-164 (2001).
Herts et al., “Power injection of contrast media using central venous catheters: feasibility, safety, and efficacy,” AJR Am. J. Roentgenol., vol. 176, No. 2, pp. 447-453 (2001).
Roth et al., “Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters,” Cathet. Cardiovasc. Diagn., vol. 22, No. 4, pp. 290-294 (1991).
Carlson et al., “Safety considerations in the power injection of contrast media via central venous catheters during computered tomogrphic examinations,” Invest. Radiol., vol. 27, No. 5, p. 337-340 (1992).
Kaste et al., “Safe use of powr injectors with central and peripheral venous access devices for pediatrict CT,” Pediatr. Radiol., vol. 26, No. 8, pp. 449-501 (1996).
Herts et al., “Power injection of intravenous contrast material through central venous catheters for CT: in vitro evaluation,” Radiology, vol. 200, No. 3, pp. 731-735 (1996).
Rivitz et al., “Power injection of peripherally inserted central catheters,” J. Vasc. Interv. Radiol., vol. 8, No. 5, pp. 857-863 (1997).
Rogalla et al., Safe and easy power injection of contrast material through a central line, Eur. Radiol., vol. 8, No. 1, pp. 148-149 (1998).
Williamson et al., “Assessing the adequacy of peripherally inserted central catheters for power injection of intravenous contrast agents for CT,” J. Comput. Assist. Tomogr., vol. 25, No. 6, pp. 932-937 (2001).
Chahous et al., “Randomized comparison of coronary angiography using 4F catheters: 4F manual versus ‘Acisted’ power injection technique,” Catheter Cardiovasc. Interv., vol. 53, No. 2, pp. 221-224 (2001).
Walsh et al., “Effect of contrast agent viscosity and injection flow velocity on bolus injection pressures for peripheral venous injection in first-pass myocardial perfusion studies,” Technol. Health Care, vol. 10, No. 1, pp. 57-63 (2002).
Saito et al., “Diagnostic brachial coronary arteriography using a power-assisted injector and 4 French catheters with new shamps,” J. Invasive Cardiol., vol. 9, No. 7, pp. 461-468 (1997).
International Search Report and Written Opinion mailed Mar. 18, 2010 for International Application No. PCT/US2010/021740 (7 pages).
International Preliminary Report on Patentability mailed Aug. 2, 2011 for International Application No. PCT/US2010/021740 (7 pages).
Related Publications (1)
Number Date Country
20120136301 A1 May 2012 US
Continuations (1)
Number Date Country
Parent 12362004 Jan 2009 US
Child 13303551 US